Pharma Shakeup: Trump's Price Cut Order Sends Ripples Through Industry
Published on: May 13, 2025, 6:30 p.m. | Source: Devdiscourse
Recent health briefs reveal significant developments in the pharmaceutical sector. Key highlights include Trump's order demanding price cuts from drugmakers, Grifols' profit surge, and Cytokinetics' promising heart disease drug. Meanwhile, Novartis and Eli Lilly make strategic moves despite potential challenges from Trump's pricing mandates.
